SCHEMBL8905948

SCHEMBL8905948

COc1ccccc1CCNCC(O)COc1cccc2[nH]c3ccccc3c12

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 8/20 0.76
TLR4 O00206 4/20 0.76
ADRB3 P13945 4/20 0.76
DRD2 P14416 3/20 0.76
MAPT P10636 2/20 0.76
DNM1 Q05193 2/20 0.76
ADRB1 P08588 2/20 0.76
KDM4E B2RXH2 1/20 0.76
SLC22A2 O15244 1/20 0.76
SLC22A1 O15245 1/20 0.76
MLNR O43193 1/20 0.76
NR1I2 O75469 1/20 0.76
KCNK2 O95069 1/20 0.76
ABCB11 O95342 1/20 0.76
APP P05067 1/20 0.76
ABCB1 P08183 1/20 0.76
HTR1A P08908 1/20 0.76
ADRA2A P08913 1/20 0.76
ADORA3 P0DMS8 1/20 0.76
GAA P10253 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17950795 0.94 ADRB2 (0.74) ADRB2TLR4ADRB3DRD2MAPT
SCHEMBL16550176 0.88 ADRB2 (0.77) ADRB2TLR4ADRB3DRD2MAPT
SCHEMBL7413972 0.88 ADRB2 (0.59) ADRB2TLR4ADRB3DRD2MAPT
Carvedilol SCHEMBL29687280 0.87 ADRB2 (1.00) ADRB2TLR4ADRB3DRD2MAPT
Carvedilol SCHEMBL1172788 0.87 ADRB2 (1.00) ADRB2TLR4ADRB3DRD2MAPT
Carvedilol SCHEMBL29370188 0.87 ADRB2 (1.00) ADRB2TLR4ADRB3DRD2MAPT
Carvedilol SCHEMBL29744884 0.87 ADRB2 (1.00) ADRB2TLR4ADRB3DRD2MAPT
(R)-Carvedilol SCHEMBL232110 0.87 ADRB2 (1.00) ADRB2TLR4ADRB3DRD2MAPT
Carvedilol SCHEMBL1560204 0.87 ADRB2 (1.00) ADRB2TLR4ADRB3DRD2MAPT
Carvedilol SCHEMBL10082334 0.87 ADRB2 (1.00) ADRB2TLR4ADRB3DRD2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115960032-A Aryloxy propanol amine beta-adrenaline receptor ligand with beta-arrestin biased agonistic activity and application thereof 复旦大学 2023-04-14 CN disclosed
US-9920095-B2 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders SYNERGY PHARMACEUTICALS, INC. (US) 2018-03-20 US disclosed
US-20160200766-A1 AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS SOLTA MEDICAL IRELAND LIMITED (IE) 2016-07-14 US disclosed
US-5643915-A ANTIINFLAMMATORY AGENTS ANDRULIS PHARMACEUTICALS CORP. (US) 1997-07-01 US disclosed